2016. Adherence and/or discontinuation of imatinib mesylate in patients with chronic myeloid leukemia . Brazilian Journal of Pharmaceutical Sciences. 52, 4 (Dec. 2016), 581–589. DOI:https://doi.org/10.1590/s1984-82502016000400001.